# PTC Therapeutics, Inc. (PTCT)

PTC Therapeutics withdraws NDA resubmission for Duchenne treatment after FDA doubts efficacy data. This follows recent news of regulatory updates on Translarna.

### About PTC Therapeutics, Inc.
PTC Therapeutics, Inc. is a biopharmaceutical company focused on developing and commercializing treatments for rare diseases.  
PTC Therapeutics, Inc. uses the ticker $PTCT for trading. Listed in the [Stocks](/list/stocks) category within the [Healthcare](/list/stocks/healthcare) sectors.

### Insights
- PTC Therapeutics, Inc. (PTCT) social dominance hit [------] which is 123% higher than it's daily average.
- PTC Therapeutics, Inc. (PTCT) posts created is up 90.91% from the previous week.

### Price: $69.50
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:$ptct/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/$ptct/time-series/close.tsv)  
The stock price is near its 52-week high, supported by positive analyst sentiment and increased social media activity, which are currently outweighing negative news regarding the FDA's rejection of Vatiquinone.  

24-Hour: -1.77%
7-Day: -7%
30-Day: -4.18%

1-Year High: $86.30 on 2025-11-26  
1-Year Low: $36.20 on 2025-05-06  
  
  
### AltRank: [-----]
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:$ptct/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/$ptct/time-series/alt_rank.tsv)  
PTC Therapeutics, Inc. (PTCT) is currently AltRank #1,178 based on combined combined social and market metrics
Daily Average: [---]  
[--] Week: [-----] +1,278  
[--] Month: [-----] +2  
[--] Months: [-----] +992  
[--] Year: [-----] +840  
1-Year High: [-----] on 2026-02-12  
1-Year Low: [--] on 2025-09-13  
  
  
### Galaxy Score: [-----]
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:$ptct/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/$ptct/time-series/galaxy_score.tsv)  
Current Value: [-----]  
Daily Average: [--]  
[--] Week: [--] [---]  
[--] Month: [--] +9  
[--] Months: [--] [---]  
[--] Year: [--] [---]  
1-Year High: [--] on 2025-06-23  
1-Year Low: [--] on 2026-01-27  
  
  
### Engagements: [-----] (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$ptct/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$ptct/time-series/interactions.tsv)  
Current Value: [-----]  
Daily Average: [-----]  
[--] Week: [------] +5.40%  
[--] Month: [------] +5.60%  
[--] Months: [-------] -30%  
[--] Year: [---------] +4.30%  
1-Year High: [------] on 2025-07-28  
1-Year Low: [---] on 2026-02-08  

Engagements by network (24h):
X: [---]
News: [--]
TikTok: [--]
Reddit: [--]
Instagram: [--]
YouTube: [--]

  
  
### Mentions: [--] (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$ptct/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$ptct/time-series/posts_active.tsv)  
Current Value: [--]  
Daily Average: [--]  
[--] Week: [--] -14%  
[--] Month: [---] -17%  
[--] Months: [-----] -33%  
[--] Year: [-----] +46%  
1-Year High: [---] on 2025-06-30  
1-Year Low: [--] on 2026-01-02  

Mentions by network (24h):
X: [--]
News: [--]
TikTok: [--]
Reddit: [--]
Instagram: [--]
YouTube: [--]

  
  
### Creators: [--] (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$ptct/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$ptct/time-series/contributors_active.tsv)  
[--] unique social accounts have posts mentioning PTC Therapeutics, Inc. (PTCT) in the last [--] hours which is no change from in the previous [--] hours
Daily Average: [--]  
[--] Week: [--] -5%  
[--] Month: [---] no change  
[--] Months: [---] -53%  
[--] Year: [-----] +68%  
1-Year High: [---] on 2025-06-30  
1-Year Low: [--] on 2025-10-12  

The most influential creators that mention PTC Therapeutics, Inc. in the last [--] hours

| Creator                                              | Rank | Followers | Posts | Engagements |
| -------                                              | ---- | --------- | ----- | ----------- |
| [@BehaviorFin](/creator/twitter/BehaviorFin)         | [--]    | [-----]     | [--]     | [--]          |
| [@avinash_redekar](/creator/twitter/avinash_redekar) | [--]    | [------]    | [--]     | [--]          |
| [@notdumbmoney](/creator/twitter/notdumbmoney)       | [--]    | [---]       | [--]     | [--]           |

[View More](/list/creators/$ptct/100)
  
  
### Sentiment: 67%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$ptct/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$ptct/time-series/sentiment.tsv)  
Current Value: 67%  
Daily Average: 82%  
[--] Week: 20% -80%  
[--] Month: 20% -80%  
[--] Months: 20% -35%  
[--] Year: 20% -63%  
1-Year High: 100% on 2025-03-25  
1-Year Low: 14% on 2025-04-12  

Most Supportive Themes:
- Positive Analyst Ratings and Price Targets: (35%) Analysts are issuing positive ratings and price targets for PTCT, indicating potential for stock price appreciation.
- Mentions in AI and Momentum Stock Screeners: (30%) PTCT is being recognized in AI-driven stock rankings and momentum screeners, suggesting favorable technical and fundamental indicators.
- Inclusion in Biotech Stock Lists: (15%) The company is being highlighted in lists of strong biotech stocks, reflecting positive sentiment within the broader biotechnology sector.
  
Most Critical Themes:
- FDA Complete Response Letter for Vatiquinone: (40%) The FDA has issued a Complete Response Letter for Vatiquinone, citing insufficient efficacy, which is a significant negative development.
  
  
  
### Social Dominance: 0.00295%
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$ptct/c:line/m:social_dominance/iv:1d.svg)  
[Social Dominance 24-Hour Time-Series Raw Data](/topic/$ptct/time-series/social_dominance.tsv)  
Current Value: 0.00295%  
Daily Average: 0.00908%  
[--] Week: 0.00309% -0.0004100000000000002%  
[--] Month: 0.02% +0.017%  
[--] Months: 0.02% +0.0088%  
[--] Year: 0.02% +0.0079%  
1-Year High: 0.046% on 2025-03-29  
1-Year Low: 0.0019% on 2025-10-12  
  
  
### Market Dominance: 0.00631%
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$ptct/c:line/m:market_dominance/iv:1d.svg)  
[Market Dominance 24-Hour Time-Series Raw Data](/topic/$ptct/time-series/market_dominance.tsv)  
Current Value: 0.00631%  
Daily Average: 0%  
1-Year High: 0.139% on 2025-04-09  
1-Year Low: 0.00416% on 2025-05-06  
  
  
### Market Cap: $5,576,022,782
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:$ptct/c:line/m:market_cap/iv:1d.svg)  
[Market Cap 24-Hour Time-Series Raw Data](/topic/$ptct/time-series/market_cap.tsv)  
Current Value: $5,576,022,782  
Daily Average: $4,825,807,159  
[--] Week: $5,576,022,782 -6.90%  
[--] Month: $5,576,022,782 -8.20%  
[--] Months: $5,576,022,782 +41%  
[--] Year: $5,576,022,782 +65%  
1-Year High: $6,924,866,306 on 2025-11-26  
1-Year Low: $2,868,311,518 on 2025-05-06  

### Top PTC Therapeutics, Inc. Social Posts
Top posts by engagements in the last [--] hours

*Showing a maximum of [--] top social posts without a LunarCrush subscription.*

"This caught my attention $LYEL $FATE $ALLO $CRBU $ADPT $PSNL $BNR $NTRA $TWST $GH $EXAS $NVTA $PSNL $BNR $NTRA $TWST $GH $EXAS $NVTA $ZNTL $EOLS $PTCT $VKTX $MCRB $JANX $NKTX $CARM $FHTX $KURA $VOR $MRUS $RCKT $ARQT $SANA $DYN $FULC 🛑 Stop Scrolling. $PROP SMALL-CAP OIL IS HEATING UP Prairie Operating Co. is building something BIG in the DJ Basin 💥 Explosive revenue EBITDA & production growth 💥 Oil-weighted assets = stronger margins in a rising crude environment 💥 Strategic acquisitions adding https://t.co/nFWsHPltVX 🛑 Stop Scrolling. $PROP SMALL-CAP OIL IS HEATING UP Prairie Operating"  
[X Link](https://x.com/shabeezy84/status/2022352920516120985) [@shabeezy84](/creator/x/shabeezy84) 2026-02-13T16:51Z [--] followers, [---] engagements


"📌 Biotech Stock News 2/13 @ Open $IMUX 26% $400M Private Placement $EVMN 14% $125M Private Placement $ANRO 5% Completion of Ph2 Study ALTO-101 $EBS 3% sNDA Approval for NARCAN Nasal Spray $GLTO 2% Closing of Public Offering $AZN 1% Results from KALOS and LOGOS trials $PTCT 0% Regulatory Update on Translarna $ITRM -5% Business Update $CHRS -13% Pricing of Public Offering $OKYO -25% Pricing of $20M Offering See the image and comments for more details 👇 https://twitter.com/i/web/status/2022352228829532451 https://twitter.com/i/web/status/2022352228829532451"  
[X Link](https://x.com/BiopharmIQ/status/2022352228829532451) [@BiopharmIQ](/creator/x/BiopharmIQ) 2026-02-13T16:48Z 28.9K followers, [----] engagements


"PTC Therapeutics has withdrawn its NDA resubmission for a Duchenne treatment after the FDA doubted the data would meet its effectiveness threshold. https://endpoints.news/ptc-therapeutics-withdraws-us-filing-for-troubled-duchenne-treatment-translarna/utm_source=Twitter&utm_medium=organic_social&utm_campaign=editorial&utm_content= https://endpoints.news/ptc-therapeutics-withdraws-us-filing-for-troubled-duchenne-treatment-translarna/utm_source=Twitter&utm_medium=organic_social&utm_campaign=editorial&utm_content="  
[X Link](https://x.com/endpts/status/2022317331091746897) [@endpts](/creator/x/endpts) 2026-02-13T14:29Z 31.2K followers, [----] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing